GoodRx Holdings, Inc.

NASDAQ:GDRX

7.35 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Revenue 200.61197.88196.644179.958189.677183.986184.109187.318191.798203.329213.256195.102176.635160.431153.544140.453123.295133.408113.256101.74591.53486.612
Cost of Revenue 28.83528.4157.50618.72116.33916.69517.3617.39518.04412.2813.92711.27111.0910.4289.2047.546.8246.0194.5963.3963.1423.012
Gross Profit 171.775169.47139.138161.237173.338167.291166.749169.923173.754191.049199.329183.831165.545150.003144.34132.913116.471127.389108.6698.34988.39283.6
Gross Profit Ratio 0.8560.8560.7080.8960.9140.9090.9060.9070.9060.940.9350.9420.9370.9350.940.9460.9450.9550.9590.9670.9660.965
Reseach & Development Expenses 30.85431.01731.53239.61131.28532.90836.7735.92135.40435.04235.0635.07329.56726.1623.68315.84611.96210.3259.827.8445.9975.818
General & Administrative Expenses 27.58941.10830.37135.31727.18829.61928.58149.54834.7431.92335.37435.94739.57943.786340.753108.4796.3325.8874.5274.1023.4352.545
Selling & Marketing Expenses 93.45489.96493.75191.61580.4678.52284.12886.21594.33892.95106.49195.65188.38179.69474.9465.11351.9263.16254.32844.9537.76638.845
SG&A 120.303118.023123.057126.932107.648108.141112.709135.763129.078124.873141.865131.598127.96123.48415.693173.59258.25269.04958.85549.05241.20141.389
Other Expenses 16.96515.94243.608-2.216.09714.93915.53313.95213.31911.37310.64810.1618.3695.3610.002-0.0010.0160.005-2.970.00400
Operating Expenses 151.157149.04154.589199.567155.03155.988165.012185.636177.801171.288187.573176.832165.896155.001443.78194.59874.73583.71972.89360.50550.32550.568
Operating Income 20.61820.43-15.451-38.3318.30816.7297.182-12.793-3.1919.76111.7566.999-0.351-4.998-299.44-61.68541.73643.6735.76737.84438.0733.52
Operating Income Ratio 0.1030.103-0.079-0.2130.0970.0910.039-0.068-0.0170.0970.0550.036-0.002-0.031-1.95-0.4390.3390.3270.3160.3720.4160.387
Total Other Income Expenses Net -8.972-20.137-9.184-2.2-6.24-13.133-11.927-9.478-6.969-5.817-5.903-5.915-5.893-5.8890.002-0.0010.0160.005-7.8470.004-13.103-13.673
Income Before Tax 11.6460.293-24.635-46.60112.0683.596-4.745-22.271-10.15913.9445.871.084-6.244-10.887-305.634-67.92634.99835.11217.93825.34624.96719.847
Income Before Tax Ratio 0.0580.001-0.125-0.2590.0640.02-0.026-0.119-0.0530.0690.0280.006-0.035-0.068-1.991-0.4840.2840.2630.1580.2490.2730.229
Income Tax Expense 4.9521.3021.234-8.106-46.7186.886-2.77319.463-8.7441.65145.78419.153-37.305-12.555-7.36-17.8947.6617.7662.7115.7275.3174.246
Net Income 6.694-1.009-25.869-38.49558.786-3.29-1.972-41.734-1.41512.293-39.914-18.06931.0611.668-298.274-50.03227.33727.34615.22719.61919.6510.013
Net Income Ratio 0.033-0.005-0.132-0.2140.31-0.018-0.011-0.223-0.0070.06-0.187-0.0930.1760.01-1.943-0.3560.2220.2050.1340.1930.2150.116
EPS 0.018-0.003-0.064-0.0930.14-0.008-0.005-0.1-0.0030.03-0.1-0.0440.080.004-0.74-0.210.0710.0770.0430.0550.0870.044
EPS Diluted 0.017-0.003-0.064-0.0930.14-0.008-0.005-0.1-0.0030.029-0.097-0.0440.070.004-0.74-0.210.0710.0750.0430.0540.0870.044
EBITDA 37.58336.37229.2391.14342.21931.66822.7151.15910.12931.18622.42117.1738.0310.379-295.014-56.50246.31448.09532.27341.72840.94336.393
EBITDA Ratio 0.1870.1840.1490.0060.2230.1720.1230.0060.0530.1530.1050.0880.0450.002-1.921-0.4020.3760.3610.2850.410.4470.42